{"id":"NCT00319501","sponsor":"Pfizer","briefTitle":"Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.","officialTitle":"A Phase 3, Randomized, Double-blind, Parallel, Placebo-controlled, Multicenter Study, With Optional Open-label Continuation, Of The Efficacy And Safety Of Vanquix(tm) Auto-injector (Diazepam Injection) For The Management Of Selected, Refractory, Patients With Epilepsy Who Require Intermittent Medical Intervention To Control Episodes Of Acute Repetitive Seizures","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-01","primaryCompletion":"2014-07","completion":"2014-07","firstPosted":"2006-04-27","resultsPosted":"2016-08-16","lastUpdate":"2016-09-23"},"enrollment":234,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Seizures","Epilepsies, Partial","Epilepsy, Complex Partial","Epilepsy, Generalized","Epilepsy"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Vanquix Auto-Injector (Diazepam Injection)","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Diazepam","type":"EXPERIMENTAL"}],"summary":"To evaluate the efficacy and safety of diazepam in the management of refractory epilepsy in selected patients who require intermittent medical intervention for the control of episodes of acute repetitive seizures. In addition, to assess the support provided by caregivers who are not themselves or not under the direct supervision of health care professionals at the time of administration.","primaryOutcome":{"measure":"Time to Next Seizure or Rescue Medication During the Double-blind Period (Kaplan-Meier 50th Percentile)","timeFrame":"From 15 minutes to 12 hours after study drug administration for an episode of ARS during the Double-blind Period","effectByArm":[{"arm":"Diazepam","deltaMin":5.92,"sd":null},{"arm":"Placebo","deltaMin":null,"sd":null}],"pValues":[{"comp":"OG000","p":"0.012"}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":8},"locations":{"siteCount":86,"countries":["United States"]},"refs":{"pmids":["24111974"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=K826-05-3001&StudyName=Efficacy%20and%20safety%20of%20Vanquix%20for%20the%20management%20of%20selected%2C%20refractory%2C%20patients%20with%20epilepsy%20who%20require%20intermittent%20caregiver"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":81},"commonTop":["INJECTION SITE PAIN","HEADACHE","INJECTION SITE HEMORRHAGE","PYREXIA","SOMNOLENCE"]}}